Company intelligence / Profile preview
Jiangsu Kanion Pharmaceutical
- Ownership
- Private
- Employees
- ~6132
- Development stage
- Other
Overview
Jiangsu Kanion Pharmaceutical is a commercial-stage, China-based pharmaceutical company specializing in research, development, production, and sales of traditional Chinese medicines and proprietary pharmaceuticals. Its portfolio includes products for anti-infective, orthopedic, gynecological, cardiovascular, and general health indications, with both prescription and over-the-counter products widely marketed in China.[1][2]
- Therapeutic areas
- Infectious DiseasesCardiovascularOtherNeurologyWomen's Health
- Modalities
- Small moleculeHerbal extractBiologic
- Industry
- Biotech
Drug pipeline
50 assets49 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Jiangsu Kanion Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jiangsu Kanion Pharmaceutical.